Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

The debate on banning asbestos.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2001
Same author

Obesity and lung function.

Thorax·2001
Same author

Radiographic abnormalities in long-tenure Vermont granite workers and the permissible exposure limit for crystalline silica.

Journal of occupational and environmental medicine·2001
Same author

Rise and fall of the FEV(1).

Chest·2000
Same author

Air pollution and death.

Journal of the Royal Society of Medicine·2000
Same author

How long are TB patients infectious?

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2000

関連する実験動画

Updated: Jul 12, 2026

A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust
10:45

A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust

Published on: January 6, 2023

炭鉱労働者の肺炎症.

W K Morgan, C E Andrews

    Science (New York, N.Y.)
    |April 21, 1972
    PubMed
    まとめ

    No abstract available in PubMed .

    さらに関連する動画

    Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
    05:18

    Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters

    Published on: July 12, 2024

    Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica
    05:03

    Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica

    Published on: October 28, 2022

    関連する実験動画

    Last Updated: Jul 12, 2026

    A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust
    10:45

    A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust

    Published on: January 6, 2023

    Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
    05:18

    Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters

    Published on: July 12, 2024

    Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica
    05:03

    Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica

    Published on: October 28, 2022